Results for tag: "HIV 1 Integrase"

HIV 1 Integrase is a class of antiretroviral drugs used to treat HIV/AIDS. It works by inhibiting the HIV 1 Integrase enzyme, which is responsible for the integration of HIV 1 DNA into the host cell's genome. This prevents the virus from replicating and spreading throughout the body. HIV 1 Integrase inhibitors are used in combination with other antiretroviral drugs to form a highly active antiretroviral therapy (HAART) regimen. This combination therapy is the most effective way to treat HIV/AIDS and reduce the risk of drug resistance. The HIV 1 Integrase market is highly competitive, with several major pharmaceutical companies offering products. These include Gilead Sciences, Merck & Co., ViiV Healthcare, and Bristol-Myers Squibb. Other companies such as Janssen Pharmaceuticals, AbbVie, and GlaxoSmithKline also offer HIV 1 Integrase inhibitors. Show Less Read more